Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on November 6, 2026

Nov. 6, 2026

Paul Mueller Company Announces Quarterly Cash Dividend

Indeterminate GlobeNewswire

Nov. 6, 2026

Maxus Mining Announces Flow-Through Financing

Indeterminate GlobeNewswire

Nov. 6, 2026

Constellation Software Inc. Announces Results for the Third Quarter Ended September 30, 2026 and Declares Quarterly Dividend

Indeterminate GlobeNewswire

Nov. 6, 2026

PyroGenesis Schedules 2026 Third Quarter Financial Results and Business Update Conference Call

Indeterminate GlobeNewswire

Nov. 6, 2026

Global Uranium Closes $932,736 Life Financing

Indeterminate GlobeNewswire

Nov. 6, 2026

Parker Scheduled to Present at Robert W. Baird Global Industrial Conference on November 10 at 10:50 a.m. Central Time (11:50 a.m. Eastern Time)

Indeterminate GlobeNewswire

Nov. 6, 2026

Surrozen to Present at Upcoming Healthcare Investor Conference

Indeterminate GlobeNewswire

Nov. 6, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Anywhere Active Launches Virtual Fitness Platform for Public Libraries and Community Organizations

Indeterminate GlobeNewswire

Nov. 6, 2026

Entera Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 6, 2026

Crown Castle to Present at the Morgan Stanley 2026 European Technology, Media & Telecom Conference

Indeterminate GlobeNewswire

Nov. 6, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Nov. 6, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

National Tirzepatide Online Telehealth Provider Ozari Health Launches Ozari Select Monthly Plan in All 50 States

Indeterminate GlobeNewswire

Nov. 6, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026

Indeterminate GlobeNewswire